🇺🇸 FDA
Pipeline program

eythrocytapheresis

PPO-C-02-15

Phase 3 other completed

Quick answer

eythrocytapheresis for Pre Operative Autologous Donation is a Phase 3 program (other) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Atrium Therapeutics
Indication
Pre Operative Autologous Donation
Phase
Phase 3
Modality
other
Status
completed

Clinical trials